Pharmaceutical Research And Manufacturers Of America Fnd Inc is located in Washington, DC. The organization was established in 1965. According to its NTEE Classification (E60) the organization is classified as: Health Support, under the broad grouping of Health Care and related organizations. As of 12/2021, Pharmaceutical Research And Manufacturers Of America Fnd Inc employed 3 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Pharmaceutical Research And Manufacturers Of America Fnd Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Pharmaceutical Research And Manufacturers Of America Fnd Inc generated $3.7m in total revenue. The organization has seen a slow decline revenue. Over the past 7 years, revenues have fallen by an average of (1.9%) each year. All expenses for the organization totaled $4.4m during the year ending 12/2021. As we would expect to see with falling revenues, expenses have declined by (0.3%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2017, Pharmaceutical Research And Manufacturers Of America Fnd Inc has awarded 25 individual grants totaling $950,285. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
SEE SCHEDULE O
Describe the Organization's Program Activity:
Part 3 - Line 4a
VALUE ASSESSMENT - INITIATIVE TO DEVELOP STRATEGIES TO BETTER ASSESS THE VALUE OF MEDICINES AND HEALTH CARE SERVICES WHILE IMPROVING PATIENT OUTCOMES AND REDUCING INEFFICIENCY IN HEALTH CARE.
HEALTH OUTCOMES - OUTCOMES RESEARCH SPANS A BROAD SPECTRUM OF ISSUES FROM STUDIES EVALUATING THE EFFECTIVENESS OF A PARTICULAR PHARMACEUTICAL INTERVENTION TO THE IMPACT OF REIMBURSEMENT. THIS PROGRAM SUPPORTS YOUNG SCIENTISTS WITH STIPEND AND RESEARCH SUPPORT.
DRUG DELIVERY - THE PROGRAM EMPHASIZES THE QUANTITATIVE UNDERSTANDING AND USE OF THE PRINCIPLES UNDERLYING DRUG TRANSPORT, ROUTE OF ADMINISTRATION, FORMULATION COMPOSITION, TECHNOLOGY DEVELOPMENT AND MANUFACTURING/ENGINEERING ASPECTS INTENDED TO IMPROVE DRUG PRODUCT SAFETY AND EFFICACY, INCLUDING PATIENT COMPLIANCE.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Eileen Cannon President (thru 9/30/2021) | Officer | 37.5 | $534,005 |
Amy Miller President | Officer | 37.5 | $222,578 |
Joanne Westphal Director | 37.5 | $176,259 | |
Andrew Plump MD PHD Chairman | OfficerTrustee | 1 | $0 |
Alfred W Sandrock MD PHD Chairman (thru 12/3/2021) | OfficerTrustee | 1 | $0 |
Michael Dolsten MD PHD Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $2,764,822 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $2,764,822 |
Total Program Service Revenue | $0 |
Investment income | $407,496 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $520,848 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $3,693,166 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $36,991 |
Grants and other assistance to domestic individuals. | $2,913,766 |
Grants and other assistance to Foreign Orgs/Individuals | $5,000 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $594,436 |
Compensation of current officers, directors, key employees. | $136,315 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $128,350 |
Other employee benefits | $39,436 |
Payroll taxes | $44,405 |
Fees for services: Management | $0 |
Fees for services: Legal | $279 |
Fees for services: Accounting | $18,030 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $25,250 |
Fees for services: Other | $392,243 |
Advertising and promotion | $23,488 |
Office expenses | $2,346 |
Information technology | $17,678 |
Royalties | $0 |
Occupancy | $0 |
Travel | $5,744 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $19,035 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $7,349 |
All other expenses | $0 |
Total functional expenses | $4,358,423 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $922,819 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $386 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $18,676 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $25,288,879 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $26,230,760 |
Accounts payable and accrued expenses | $153,182 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $19,307 |
Total liabilities | $172,489 |
Net assets without donor restrictions | $26,058,271 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $26,230,760 |
Over the last fiscal year, Pharmaceutical Research And Manufacturers Of America Fnd Inc has awarded $25,991 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
Santa Monica, CA PURPOSE: VAI Project | $14,991 |
Fairfax, VA PURPOSE: AFPE Pre doctoral fellowship | $11,000 |
Over the last fiscal year, we have identified 2 grants that Pharmaceutical Research And Manufacturers Of America Fnd Inc has recieved totaling $129,022.
Awarding Organization | Amount |
---|---|
Pharmaceutical Research And Manufacturers Of America Washington, DC PURPOSE: General Contribution | $129,000 |
Amazonsmile Foundation Seattle, WA PURPOSE: GENERAL SUPPORT | $22 |
Organization Name | Assets | Revenue |
---|---|---|
Ehealth Africa Washington, DC | $6,476,528 | $16,565,082 |
Colorectal Cancer Alliance Inc Washington, DC | $11,286,875 | $14,624,041 |
Arlington Free Clinic Inc Arlington, VA | $10,623,564 | $5,707,203 |
Maryland Community Health Initiatives Baltimore, MD | $771,484 | $4,218,123 |
Fredericksburg Area Regional Health Council Inc Fredericksburg, VA | $3,229,753 | $4,303,398 |
Pharmaceutical Research And Manufacturers Of America Fnd Inc Washington, DC | $26,230,760 | $3,693,166 |
Whole Womans Advocacy Alliance Charlottesville, VA | $2,944,404 | $5,509,310 |
Cornerstone Support Services Providence Forge, VA | $1,749,824 | $3,920,333 |
American College Of Osteopathic Internists Inc Arlington, VA | $6,444,455 | $4,032,744 |
Foreign Credentialing Commission On Physical Therapy Alexandria, VA | $7,542,229 | $2,840,104 |
Healthcare Ready Washington, DC | $2,980,753 | $3,148,420 |
Give An Hour Nonprofit Corporation Clarksburg, MD | $1,609,374 | $1,965,444 |